These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 4597950)

  • 41. Beta-blocking therapy: Propranolol.
    Pettinger WA
    Postgrad Med; 1974 Oct; 56(5):68-73. PubMed ID: 4412183
    [No Abstract]   [Full Text] [Related]  

  • 42. [Drug combinations in the treatment of primary arterial hypertension].
    Angelino PF
    Minerva Med; 1975 Feb; 66(13):602-11. PubMed ID: 1113910
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Experience with the combination of beta receptor blockader and hydralazine in the treatment of hypertension].
    Jensen HE; Rasmussen K
    Ugeskr Laeger; 1976 Mar; 138(14):860-3. PubMed ID: 772901
    [No Abstract]   [Full Text] [Related]  

  • 44. Vasodilation in treatment of hypertension.
    Chidsey CA
    N Engl J Med; 1970 May; 282(19):1102-3. PubMed ID: 4392414
    [No Abstract]   [Full Text] [Related]  

  • 45. Vasodilation for vasospastic hypertension.
    Koch-Weser J
    N Engl J Med; 1973 Jul; 289(4):213-4. PubMed ID: 4712992
    [No Abstract]   [Full Text] [Related]  

  • 46. [Pharmacokinetic properties and indications for modern vasodilators. 1. Pharmacodynamic properties of vasodilators].
    Langnickel R; Bluth R
    Z Arztl Fortbild (Jena); 1985; 79(19):821-5. PubMed ID: 2866637
    [No Abstract]   [Full Text] [Related]  

  • 47. Hydralazine-induced lupus.
    Singh S
    South Med J; 2006 Jan; 99(1):6-7. PubMed ID: 16466108
    [No Abstract]   [Full Text] [Related]  

  • 48. Management of systemic hypertension in children.
    Reisman L; Selden RV
    Pediatr Ann; 1982 Jul; 11(7):604-5, 607-10, 612-3. PubMed ID: 7050855
    [No Abstract]   [Full Text] [Related]  

  • 49. Influence of extracellular fluid volume on response to antihypertensive drugs.
    Finnerty FA; Davidov M; Mroczek WJ; Gavrilovich L
    Circ Res; 1970 Jul; 27(1 Suppl 1):71-82. PubMed ID: 5450158
    [No Abstract]   [Full Text] [Related]  

  • 50. Sodium nitroprusside: a review of its clinical effectiveness as a hypotensive agent.
    Tuzel IH
    J Clin Pharmacol; 1974 Oct; 14(10):494-503. PubMed ID: 4610012
    [No Abstract]   [Full Text] [Related]  

  • 51. Reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: guidelines for determining a pulmonary vasodilator response.
    Rich S; Martinez J; Lam W; Levy PS; Rosen KM
    Am Heart J; 1983 Jan; 105(1):119-27. PubMed ID: 6849224
    [No Abstract]   [Full Text] [Related]  

  • 52. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs.
    Evgenov OV; Ichinose F; Evgenov NV; Gnoth MJ; Falkowski GE; Chang Y; Bloch KD; Zapol WM
    Circulation; 2004 Oct; 110(15):2253-9. PubMed ID: 15466650
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Forum on hypertension. Part 5. New anti-hypertensive agents in the therapy of hypertension].
    Holzgreve H
    MMW Munch Med Wochenschr; 1981 May; 123(21):suppl 80-6. PubMed ID: 6265766
    [No Abstract]   [Full Text] [Related]  

  • 54. Acute and chronic therapy of hypertension with vasodilators.
    McKenzie JK
    Clin Invest Med; 1978; 1(3-4):163-70. PubMed ID: 391455
    [No Abstract]   [Full Text] [Related]  

  • 55. Sodium nitroprusside treatment of ergotamine-induced peripheral ischemia.
    Carliner N; Denune DP; Finch CS; Goldberg LI
    JAMA; 1974 Jan; 227(3):308-9. PubMed ID: 4859658
    [No Abstract]   [Full Text] [Related]  

  • 56. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
    Kieler-Jensen N; Lundin S; Ricksten SE
    J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Propranolol therapy in essential hypertension. Observations on predictability of therapeutic response.
    Hansson L; Zweifler AJ; Julius S; Ellis CN
    Int J Clin Pharmacol; 1974 Sep; 10(2):79-89. PubMed ID: 4448555
    [No Abstract]   [Full Text] [Related]  

  • 58. [Vasodilating-acting antihypertensive agents: model substance sodium nitroprusside].
    Kreye VA; Reske SN; Schultz KD
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():87-96. PubMed ID: 613683
    [No Abstract]   [Full Text] [Related]  

  • 59. Low doses of inhaled nitric oxide in heart transplant recipients.
    Auler Júnior JO; Carmona MJ; Bocchi EA; Bacal F; Fiorelli AI; Stolf NA; Jatene AD
    J Heart Lung Transplant; 1996 May; 15(5):443-50. PubMed ID: 8771498
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rapid control of severe hypertension with minoxidil.
    Alpert MA; Bauer JH
    Arch Intern Med; 1982 Nov; 142(12):2099-104. PubMed ID: 6753777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.